Findimmune is a biopharma company developing anticancer and immune therapies, based in France. Findimmune has developed lead candidates for the treatment of cancer, based on immune stimulation for anticancer vaccination and on the conversion of unresponsive “cold” tumors into sensitive “hot” tumors as part of anti-cancer treatments. Findimmune also works on the delivery of innovative drugs in combination with immune checkpoint inhibitors. Findimmune benefits from a drug discovery research platform (UMR-S 1030 INSERM) in partnership with the Gustave Roussy Cancer Campus, France, where FindImmune is also located. It focuses on the identification of novel therapies dedicated to the manipulation of macrophage immune checkpoints that we recently discovered and patented for both anticancer and inflammatory diseases.